Adverse effects with Avonex.
D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D004348:Drug Labeling; D006801:Humans; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000009:adverse effects*; D009103:Multiple Sclerosis / Q000188:drug therapy; D014481:United States; D014486:United States Food and Drug Administration
D000276:Adjuvants, Immunologic; D016899:Interferon-beta; D000068556:Interferon beta-1a